Benzinga | Mar 17, 2021 08:40AM EDT

Credit Suisse Maintains Outperform on Medpace Hldgs, Raises Price Target to $181

Credit Suisse maintains Medpace Hldgs (NASDAQ:MEDP) with a Outperform and raises the price target from $178 to $181.